Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mathijssen, Ron H J"'
Autor:
Agema BC; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: b.agema@erasmusmc.nl., Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Viskil M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., de Neijs MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Sassen SDT; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Koch BCP; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Joerger M; Department of Medical Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 786-793. Date of Electronic Publication: 2023 Nov 03.
Autor:
Buck SAJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands. s.buck@erasmusmc.nl., Guchelaar NAD; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Ghobadi Moghaddam-Helmantel IM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Mathijssen-van Stein D; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Oct; Vol. 61 (10), pp. 1471-1473. Date of Electronic Publication: 2022 Jul 27.
Autor:
Mout L; Department of Medical Oncology Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., van Royen ME; Department of Pathology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Cancer Treatment Screening Facility Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., de Ridder C; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., Stuurman D; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., van de Geer WS; Department of Medical Oncology Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Cancer Computational Biology Center Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., Marques R; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., Buck SAJ; Department of Medical Oncology Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., French PJ; Cancer Treatment Screening Facility Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Department of Neurology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., van de Werken HJG; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Cancer Computational Biology Center Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Department of Pathology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Cancer Treatment Screening Facility Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Department of Neurology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands; Cancer Computational Biology Center Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., de Wit R; Department of Medical Oncology Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., Lolkema MP; Department of Medical Oncology Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands., van Weerden WM; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands. Electronic address: w.vanweerden@erasmusmc.nl.
Publikováno v:
EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103681. Date of Electronic Publication: 2021 Nov 05.
Autor:
van Eerden RAG; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
International journal of nanomedicine [Int J Nanomedicine] 2020 Oct 22; Vol. 15, pp. 8151-8166. Date of Electronic Publication: 2020 Oct 22 (Print Publication: 2020).
Autor:
Belderbos BPS; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., de With M; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Singh RK; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Agema BC; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., El Bouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. s.bins@erasmusmc.nl.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Mar; Vol. 85 (3), pp. 547-553. Date of Electronic Publication: 2020 Jan 01.
Autor:
Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Cancer Genomics Netherlands, Rotterdam, The Netherlands., Onstenk W; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., De Laere B; GZA Hospitals Sint-Augustinus, Wilrijk, Belgium.; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., Dirix LY; GZA Hospitals Sint-Augustinus, Wilrijk, Belgium.; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands., Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., Meulenbeld HJ; Department of Internal Medicine, Gelre Ziekenhuizen, Zutphen, The Netherlands., Creemers GJ; Department of Internal Medicine, Catharina Ziekenhuis, Eindhoven, The Netherlands., van Weerden WM; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Jenster GW; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Nieuweboer AJM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Cancer Genomics Netherlands, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2019 Aug; Vol. 13 (8), pp. 1795-1807. Date of Electronic Publication: 2019 Jun 28.
Autor:
Belderbos BPS; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Leeuwen RWF; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Meer N; Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Overkleeft ENM; Department of Internal Medicine, Ikazia Hospital, Rotterdam, the Netherlands., van der Deure WM; Department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. a.mathijssen@erasmusmc.nl.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Feb 01; Vol. 24 (3), pp. 541-546. Date of Electronic Publication: 2017 Nov 17.
Autor:
Nieuweboer AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Graan AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Soest RJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Alphen RJ; Department of Internal Medicine, TweeSteden Ziekenhuis, Tilburg, the Netherlands., Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, the Netherlands., van Halteren H; Department of Internal Medicine, Admiraal de Ruyter Ziekenhuis, Goes/Vlissingen, the Netherlands., Ten Tije AJ; Department of Internal Medicine, Amphia Ziekenhuis, Breda, the Netherlands., Zuetenhorst H; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., van der Meer N; Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Chitu D; Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. a.mathijssen@erasmusmc.nl.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Apr 01; Vol. 23 (7), pp. 1679-1683. Date of Electronic Publication: 2016 Oct 04.
Autor:
Azaro A; Molecular Therapeutics Research Unit, Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. aazaro@vhio.net.; Pharmacology Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. aazaro@vhio.net., Rodón J; Molecular Therapeutics Research Unit, Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Machiels JP; Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, Belgium., Rottey S; Department of Medical Oncology, University Hospital of Ghent and Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium., Damian S; Department of Medical Oncology, Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy., Baird R; Early Phase Clinical Trials Team, Department of Oncology, University of Cambridge, Cambridge, UK., Garcia-Corbacho J; Early Phase Clinical Trials Team, Department of Oncology, University of Cambridge, Cambridge, UK., Mathijssen RHJ; Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Clot PF; Sanofi, Chilly-Mazarin, France., Wack C; Sanofi, Chilly-Mazarin, France., Shen L; Sanofi, Bridgewater, NJ, USA., de Jonge MJA; Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Dec; Vol. 78 (6), pp. 1185-1197. Date of Electronic Publication: 2016 Oct 27.
Autor:
van Soest RJ; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl., de Morrée ES; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kweldam CF; Department of Pathology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Wiemer EA; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Weerden WM; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
European urology [Eur Urol] 2016 Mar; Vol. 69 (3), pp. e43-4. Date of Electronic Publication: 2015 Jul 30.